Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

1.4K
Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
1.4K
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

285
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
285
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

212
Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
212
Dialysis01:15

Dialysis

1.4K
Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
1.4K
Dialysis01:27

Dialysis

1.0K
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
1.0K
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

449
Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
449

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Surface N-Glycosylation Dictates MSC-EV Uptake and CCR2-Driven Monocyte Recruitment to Inflamed Endothelium Under Shear Flow.

Journal of extracellular vesicles·2026
Same author

Autosomal Dominant Tubulointerstitial Kidney Disease-UMOD: Case Report and Disease Update.

Diagnostics (Basel, Switzerland)·2026
Same author

Roadblocks of Urinary EV Biomarkers: Moving Toward the Clinic.

Journal of extracellular vesicles·2025
Same author

Sweeteners: erythritol, xylitol and cardiovascular risk-friend or foe?

Cardiovascular research·2025
Same author

RSPO1, a potent inducer of pancreatic β cell neogenesis.

Cell reports. Medicine·2025
Same author

Albuminuria Range as a Key Metric Linking Renal Function to Heart Failure Outcome in FINEARTS-HF.

Journal of the American College of Cardiology·2025

Related Experiment Video

Updated: Dec 13, 2025

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

2.9K

Proteomic Research in Peritoneal Dialysis.

Mario Bonomini1, Francesc E Borras2, Maribel Troya-Saborido2

  • 1Nephrology and Dialysis Unit, Department of Medicine, G. d'Annunzio University, Chieti-Pescara, SS. Annunziata Hospital, Via dei Vestini, 66013 Chieti, Italy.

International Journal of Molecular Sciences
|August 6, 2020
PubMed
Summary

Proteomic analysis of peritoneal dialysis effluent offers new biomarkers for early detection of complications and personalized treatment. This approach aids in monitoring peritoneal membrane health and improving patient outcomes in renal replacement therapy.

Keywords:
biomarkerend-stage renal diseaseperitoneal dialysisperitoneal dialysis effluentperitoneumproteomics

More Related Videos

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

15.8K
Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
10:31

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

510

Related Experiment Videos

Last Updated: Dec 13, 2025

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

2.9K
Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

15.8K
Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
10:31

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

510

Area of Science:

  • Nephrology
  • Proteomics
  • Biomarker Discovery

Background:

  • Peritoneal dialysis (PD) is a cost-effective renal replacement therapy (RRT) underutilized despite advantages over hemodialysis.
  • Infectious complications and solution bio-incompatibility lead to PD discontinuation by damaging the peritoneal membrane.
  • Identifying patients at risk and guiding personalized interventions requires novel biomarkers.

Purpose of the Study:

  • To review proteomic studies on PD effluent.
  • To explore the potential of omics methodology for identifying biomarkers of peritoneal membrane health.
  • To assess the relationship between biomarkers, PD prescription, and adequacy.

Main Methods:

  • Proteomic analysis of peritoneal dialysis effluent.
  • Review of existing literature on proteomic investigations in PD patients.
  • Correlation of identified proteins with inflammation, fibrosis, and encapsulating peritoneal sclerosis.

Main Results:

  • Proteomic analysis of PD effluent has identified proteins linked to inflammation and fibrosis.
  • Proteomics can detect early changes in peritoneal membrane integrity before clinical parameters are affected.
  • Specific proteins may serve as biomarkers for conditions like encapsulating peritoneal sclerosis.

Conclusions:

  • Proteomics is a powerful tool for predicting, diagnosing, and monitoring PD complications.
  • Biomarkers from PD effluent can guide personalized interventions and improve clinical outcomes.
  • Further research into omics-based biomarkers is crucial for optimizing PD therapy and ensuring peritoneal membrane welfare.